Co-Diagnostics, Inc. received a notification on July 10, 2025, from NASDAQ granting an additional 180-day grace period until January 5, 2026, to meet the $1.00 minimum bid requirement after failing initial compliance. The company plans to address this by potentially conducting a reverse stock split.